Fleetwood Mac's Christine McVie Sells Music Catalog to Hipgnosis

Christine McVie, key member of Fleetwood Mac, has joined her bandmates in selling her music catalog to Hipgnosis Songs Fund. The financial details of the deal were not disclosed (Variety).

McVie, who wrote or co-wrote 115 songs for Fleetwood Mac, is the fourth member to sell her share of the band's music rights. Previously, Stevie Nicks, Lindsey Buckingham, and Mick Fleetwood have also struck similar deals with Hipgnosis (Billboard).

Music catalog sales have become increasingly popular in the music industry, with various types of music rights being bought and sold through music rights societies and other platforms. These transactions allow artists to receive upfront payments for their catalogs, gaining financial security and liquidity (Forbes).

The sale of music catalogs involves the transfer of ownership of the copyrights and royalties of a body of songs. The buyer, in this case Hipgnosis, acquires the income streams from the songs' performances, recordings, and synchronization licenses (Music Business Worldwide).

As of now, the exact terms of McVie's deal with Hipgnosis remain undisclosed. However, this sale further solidifies the trend of music catalog investments, with more artists and bands following suit to secure their financial futures.

For more information on music rights, their ownership, and how they work, check out the following resources:

Stay up to date.
Join our newsletter.

Stockholm

Sweden

All rights reserved Anotherblock © 2024

This website (the “Platform”) is managed by Anotherblock AB. By accessing this Platform and its various pages, you agree to comply with its Privacy Policy. The Platform is intended for the use of accredited investors only, and Anotherblock AB does not guarantee the accuracy or completeness of the information provided on any of its pages. Anotherblock AB does not offer investment recommendations or provide legal, tax, or financial advice. No communication should be construed as an endorsement of any investment opportunity, and there is no guarantee that any investment valuation is precise or that any investment opportunity is appropriate for any particular accredited investor.